publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
thermor
apoptosi
may
contribut
ethanolinduc
liver
injuri
via
complement
activ
interferon
ifn
administr
main
therapi
hcvinfect
individu
still
fraction
complet
respons
treatment
sever
hcv
protein
core
protein
demonstr
attenu
ifn
respons
differ
mechan
present
studi
examin
whether
hcv
membranebound
protein
whose
function
mostli
unknown
exert
effect
ifninduc
antivir
respons
report
assay
show
significantli
suppress
ifninduc
activ
ifnstimul
respons
element
isr
promot
activ
examin
abil
hcv
confer
ifn
resist
vsv
origin
ifnsensit
viru
transrescu
assay
viral
titer
low
cell
treat
ifna
howev
significantli
increas
hcv
also
examin
effect
hcv
transcript
interferonstimul
gene
isg
qrtpcr
found
ifninduc
express
significantli
downregul
result
confirm
chromatin
immunoprecipit
chip
assay
level
activ
statu
interferonstimul
gene
factor
known
regul
ifn
pathway
also
notic
reduc
taken
togeth
result
strongli
suggest
addit
mention
hcv
protein
hcv
may
also
play
role
ifn
antagon
recent
interest
influenza
vaccin
strategi
aim
induct
crossprotect
immun
respons
heterosubtyp
viru
strain
reviv
strategi
target
activ
crossprotect
cytotox
lymphocyt
ctl
respons
direct
conserv
viral
protein
ie
nucleoprotein
np
respect
whole
inactiv
viru
wiv
vaccin
consid
good
vaccin
candid
stimul
mhc
class
irestrict
ctl
activ
noninfecti
vaccin
wiv
could
achiev
crosspresent
dendrit
cell
dc
process
involv
endocytosi
antigen
process
antigen
cytosol
proteasom
transport
transport
associ
antigen
process
tap
mhc
class
iload
compart
due
fusogen
capac
viru
deliveri
nucleocapsid
np
cytosol
activ
process
mediat
viru
sinc
viru
inactiv
protocol
use
produc
wiv
vaccin
compromis
viral
fusion
activ
potenti
could
diminish
wiv
immunogen
term
ctl
induct
therefor
investig
extent
fusion
activ
contribut
crosspresent
use
untreat
formaldehyd
fa
treat
wiv
model
fusion
activ
inact
particl
respect
found
fusion
inactiv
reduc
vitro
matur
bone
marrowderiv
dc
respons
wiv
uptak
upregul
gene
express
product
fusion
inactiv
wiv
reduc
mhc
class
irestrict
present
npderiv
epitop
previous
prime
ctl
vitro
howev
fusion
activ
play
signific
role
prime
npspecif
ctl
vivo
demonstr
vivo
cytotox
assay
data
conclud
fusion
activ
wiv
benefici
prime
ctl
unprim
individu
young
contribut
boost
ctl
respons
individu
prime
influenza
infect
earlier
life
adolesc
adult
elderli
rapid
induct
type
interferon
ifn
express
central
event
establish
innat
immun
respons
viral
infect
requir
activ
multipl
transcript
protein
follow
engag
signal
tolllik
receptordepend
independ
pathway
mani
virus
therefor
encod
factor
subvert
ifn
system
enhanc
virul
virus
belong
famili
paramyxovirida
encod
nonstructur
protein
subvert
innat
immun
respons
purpos
virus
belong
subfamili
paramyxovirina
use
protein
encod
altern
read
frame
within
phospoprotein
p
gene
member
subfamili
pneumovirina
rsv
use
protein
antagonist
protein
human
metapneumoviru
hmpv
caus
agent
sever
respiratori
tract
ill
belong
famili
paramyxovirida
subfamili
pneumovirina
hmpv
encod
p
gene
altern
read
frame
protein
relat
rsv
far
littl
known
interact
hmpv
innat
immun
system
demonstr
hmpv
block
ifn
product
pathway
earli
time
point
infect
upon
infect
cell
prototyp
strain
hmpv
transcript
rna
sensor
rigi
well
transcript
ifn
gene
regul
addit
viru
induc
transloc
nucleu
viru
abl
block
transloc
induc
sendai
viru
infect
thu
like
paramyxovirus
hmpv
counteract
innat
immun
system
earli
stage
infect
howev
hmpv
must
use
novel
mechan
type
iii
interferon
ifn
famili
elicit
antivir
respons
nearli
ident
evok
ifnab
cytokin
signal
receptor
display
tissuespecif
distribut
vivo
rapid
noncytolyt
ifnabmedi
inhibit
viru
replic
particularli
import
central
nervou
system
cn
virusor
immunemedi
destruct
infect
neuron
detriment
host
howev
much
known
regard
antivir
activ
ifnk
brain
although
ifnk
littl
antivir
activ
certain
mous
pathogen
brain
human
neuron
report
capabl
produc
respond
cytokin
found
intranas
intracrani
infect
mice
vesicular
stomat
viru
vsv
induc
mrna
express
brain
human
mrna
express
induc
vsv
infect
cultur
primari
human
brain
cell
although
rel
magnitud
ifnk
induct
substanti
express
level
still
nevertheless
low
absolut
basi
addit
found
ifnk
induc
express
ifnstimul
gene
isg
multipl
human
cn
cell
type
includ
primari
neuron
astrocyt
choroid
plexu
epitheli
endotheli
cell
howev
magnitud
isg
express
induc
ifnk
lower
activ
ifna
consequ
provid
lower
level
protect
subsequ
viru
challeng
result
show
ifnk
may
provid
protect
viru
infect
human
brain
cell
appear
play
minor
role
compar
ifnab
studi
also
support
idea
due
modest
activ
brain
therapeut
use
ifnk
chronic
hcv
infect
may
caus
fewer
neurolog
side
effect
associ
ifna
therapi
pathogenesi
sever
acut
respiratori
syndrom
coronaviru
sarscov
like
mediat
disproport
immun
respons
abil
viru
circumv
innat
immun
although
sarscov
abl
block
product
type
interferon
ifn
cell
type
human
plamacytoid
dendrit
cell
pdc
shown
produc
ifna
upon
sarscov
infect
contrast
littl
known
type
ifn
product
sarscov
infect
mice
vivo
modest
upregul
ifnb
mrna
induct
ifna
observ
balbc
mice
examin
ifn
respons
sarscov
infect
mice
murin
pdc
deriv
balbc
mice
infect
sarscov
ifn
respons
analyz
use
rtpcr
elisa
mrna
level
ifna
ifnb
ifnk
upregul
time
sarscov
infect
pdc
suggest
potent
ifn
respons
cell
protein
level
howev
ifna
could
detect
sarscov
infect
similar
result
obtain
heat
inactiv
sarscov
influenza
viru
contrast
specif
pdc
stimul
cpgodn
induc
ifna
ifnb
ifnk
mrna
level
protein
level
show
cell
capabl
produc
differ
ifn
protein
interestingli
pdc
deriv
mice
infect
sarscov
produc
ifna
protein
pdc
balbc
mice
consist
higher
ifna
mrna
level
studi
show
murin
pdc
abl
produc
ifna
sarscov
infect
product
ifnb
ifnk
seem
block
translat
level
tight
regul
ifn
product
pdc
respect
ifn
subtyp
genet
background
may
import
pathogenesi
sarscov
immediateearli
phase
host
innat
respons
viral
infect
initi
pathogen
recognit
express
earli
protect
gene
type
interferon
ifn
perform
genomescal
rna
interfer
screen
identifi
posit
neg
regul
innat
respons
sendai
viru
infect
primari
screen
individu
array
librari
lentiviralbas
short
hairpin
rna
shrna
target
human
gene
use
knock
gene
pool
shrna
per
gene
cell
line
stabli
express
luciferas
gene
control
ifnb
promot
use
strictli
standard
mean
differ
ssmd
rank
metric
select
candid
gene
posit
neg
regul
whose
silenc
significantli
modul
report
activ
cellbas
assay
valid
identifi
known
posit
regul
mav
crel
ikkb
bioinformat
analysi
gene
ontolog
go
biolog
process
molecular
function
categori
identifi
significantli
enrich
term
eight
member
ijb
kinasenfjb
cascad
among
posit
regul
repres
fold
enrich
p
candid
gene
reconfirm
test
secondari
screen
use
individu
shrnaexpress
lentivirus
minimum
shrna
per
gene
minim
select
potenti
offtarget
hit
secondari
screen
design
defin
step
newli
identifi
regul
posit
antivir
signal
cascad
approach
describ
studi
provid
signific
insight
novel
regul
host
innat
respons
viral
infect
data
primari
secondari
screen
present
type
ifn
subtyp
often
rel
speci
select
make
crossspeci
experi
difficult
interpret
syrian
golden
hamster
norwegian
rat
common
rodent
model
two
macaqu
rhesu
cynomolgu
common
nonhuman
primat
model
varieti
viral
infect
alpha
interferon
subtyp
speci
mostli
unavail
henc
either
mous
human
ifn
subtyp
frequent
use
model
system
order
understand
mous
human
alpha
ifn
subtyp
could
use
crossspeci
experi
establish
antivir
cytopath
effect
inhibit
assay
rhesu
macaqu
cynomolgu
macaqu
syrian
golden
hamster
norwegian
rat
cell
line
mous
alpha
ifn
test
hamster
rat
cell
human
subtyp
test
rhesu
cynomolgu
cell
line
gener
mous
ifnalpha
subtyp
exhibit
activ
rodent
cell
human
ifnalpha
subtyp
display
activ
macaqu
cell
howev
sever
notabl
except
certain
subtyp
littl
activ
crossspeci
assay
result
studi
may
use
identifi
select
ifnalpha
subtyp
best
use
relev
anim
model
system
